• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-05-27

  This study introduces a patient-derived gastric cancer assembloid system that integrates matched tumor organoids with diverse stromal cell subpopulations, providing a physiologically relevant in vitro model. The approach enables nuanced investigation of tumor–stroma interactions, gene expression variability, and drug response heterogeneity, supporting advancements in personalized cancer therapy research.

• Chloroquine Diphosphate (A8628): Reliable Autophagy Modulati

  2026-05-27

  Chloroquine diphosphate (SKU A8628) is a rigorously characterized autophagy modulator and TLR7/TLR9 inhibitor, enabling reproducible cell viability and proliferation assays in cancer research. This article guides scientists through real laboratory scenarios, highlighting the evidence-based advantages and workflow reliability of A8628. Explore practical solutions and protocol insights optimized for sensitivity and consistency.

• Aurora Kinase A Regulates Trained Immunity via SAM Metabolis

  2026-05-26

  Li et al. uncover a novel function of Aurora kinase A in sustaining trained immunity by regulating endogenous S-adenosylmethionine (SAM) metabolism through the mTOR-FOXO3-GNMT axis. This finding connects metabolic and epigenetic control of innate immune memory, providing mechanistic insight relevant to both immunology and cancer research.

• SNS-032 (BMS-387032): Advancing CDK Inhibition in Cancer and

  2026-05-26

  This thought-leadership article explores the mechanistic underpinnings and strategic guidance for translational researchers utilizing SNS-032 (BMS-387032). It connects rigorous cancer biology with emerging host-targeted antiviral strategies, synthesizing the latest evidence on CDK inhibition, and positions SNS-032 as a versatile tool for pioneering research at the intersection of oncology and virology.

• 2-(4,5,6,7-tetrabromo...)acetic acid: Advanced Small Molecul

  2026-05-25

  The CK2 and ERK8 inhibitor, characterized as 2-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)acetic acid, empowers researchers with high selectivity for kinase-driven signaling studies. As a DMSO-soluble, high-purity biochemical reagent, it offers precise modulation and troubleshooting flexibility for protein interaction and phase separation workflows.

• Hesperadin in Mitotic Checkpoint Dynamics: Beyond Aurora B I

  2026-05-25

  Explore Hesperadin as a potent Aurora B kinase inhibitor, emphasizing its unique role in dissecting spindle assembly checkpoint disassembly and chromosome segregation. This article delivers unparalleled insight into checkpoint regulation, setting it apart from standard cell cycle research guides.

• Azithromycin in Bacterial Infection Research: Mechanistic In

  2026-05-24

  Explore the advanced applications of Azithromycin, a macrolide antibiotic, with a focus on its mechanism, quantification, and impact on bacterial infection models. This article delivers unique assay strategies and scientific depth not found in standard protocols.

• Primidone (Mysoline): Advanced Neuroinhibition and ALS Bioma

  2026-05-23

  Explore the cutting-edge mechanisms and translational potential of Primidone (Mysoline) in neurodegenerative research. This article offers a deep dive into its unique dual inhibition profile, actionable protocol guidance, and the latest biomarker insights for ALS.

• HyperScript™ Reverse Transcriptase: Optimizing cDNA Synthesi

  2026-05-22

  HyperScript™ Reverse Transcriptase empowers precise cDNA synthesis from challenging RNA templates, enabling ultra-sensitive qPCR and transcriptomics workflows. Its thermal stability and high affinity deliver robust performance where traditional M-MLV reverse transcriptases struggle.

• LY364947: TGF-β Type I Receptor Kinase Inhibitor for EMT Res

  2026-05-22

  LY364947 enables precise modulation of the TGF-β pathway, offering unmatched reliability for epithelial-mesenchymal transition (EMT) and retinal degeneration studies. Streamlined protocols, robust inhibition of Smad2 phosphorylation, and practical troubleshooting tips make it the preferred choice for researchers seeking reproducibility and mechanistic clarity.

• Viral Induction of RIPK3 Degradation Modulates Necroptosis a

  2026-05-21

  Liu et al. reveal a viral strategy for suppressing necroptosis by targeting the necroptosis adaptor RIPK3 for ubiquitin-proteasome-mediated degradation. This work uncovers a key host-pathogen interaction that shapes viral replication and immune response, with broad implications for studies on protein degradation and innate immunity.

• Cy3-UTP in LNP Tracking: Illuminating RNA Delivery Pathways

  2026-05-21

  Explore how Cy3-UTP, a Cy3-modified uridine triphosphate, revolutionizes RNA tracking within lipid nanoparticles (LNPs). This in-depth analysis connects fluorescence RNA labeling with advanced intracellular delivery research, providing practical assay guidance and new insights for RNA-protein interaction studies.

• CK2 and ERK8 Inhibitor (SKU B7464): Reliable Kinase Modulati

  2026-05-20

  This article provides scenario-driven guidance for using the CK2 and ERK8 inhibitor (SKU B7464), a high-purity, DMSO-soluble small molecule reagent. By addressing real-world pain points in cell viability and signaling research, it demonstrates how SKU B7464 ensures reproducibility and robust data, supporting biomedical researchers seeking reliable kinase inhibition.

• Novobiocin Sodium in Advanced DNA and Antiparasitic Research

  2026-05-20

  Novobiocin Sodium, a powerful aminocoumarin antibiotic from APExBIO, is redefining DNA damage and antiparasitic workflows with high selectivity and low host toxicity. Its versatility in metabolic enzyme research and apoptosis signaling enables streamlined, reproducible protocols for complex cellular studies.

• (S)-(+)-Dimethindene maleate: Technical Guidance for M2 Anta

  2026-05-19

  (S)-(+)-Dimethindene maleate addresses the need for a selective M2 muscarinic receptor antagonist with additional H1 receptor blockade, facilitating precise dissection of autonomic, cardiovascular, and respiratory pathways in preclinical research. It is not suitable for diagnostic or therapeutic use and should not be applied in protocols requiring long-term solution stability.

15779 records 1/1052 page Next 12345 下5页 Last page